Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?
LEUKEMIA RESEARCH (2008)
Journal
LEUKEMIA RESEARCH
Volume 32, Issue 2, Pages 201-202Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Investigating the Impact of the External Environment and Benchmark Characteristics on the China-Pakistan Economic Corridor's Construction: A COVID-19 Perspective
Aidi Xu, Abdul Hameed Pitafi, Yunfeng Shang
FRONTIERS IN PSYCHOLOGY (2022)
Climate change will exacerbate population exposure to future heat waves in the China-Pakistan economic corridor
Safi Ullah, Qinglong You, Waheed Ullah, D. A. Sachindra, Amjad Ali, Asher Samuel Bhatti, Gohar Ali
WEATHER AND CLIMATE EXTREMES (2023)
Diabetes clinic reinvented: will technology change the future of diabetes care?
Marwa Al-Badri, Osama Hamdy
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2021)
Will AI ever sit at the C-suite table? The future of senior leadership
Graeme J. Watson, Kevin C. Desouza, Vincent M. Ribiere, Jaka Lindic
BUSINESS HORIZONS (2021)
The resilient economic impact of CPEC and future of MNCs: Evidence from Pakistan
Syed Umair Anwar, Wuyi Zhang, Syed Zahid Ali Shah, Qudrat Ullah, Syed Muhammad Amir, Ammara Syed
FRONTIERS IN ENVIRONMENTAL SCIENCE (2022)
Will data analytics revolution finally bring SERS to the clinic?
Ahmed Y. F. Mahmoud, Alexandra Teixeira, Marta Aranda, Maria S. Relvas, Sergio Quintero, Maria Sousa-Silva, Alexandre Chicharo, Mengkun Chen, Mohadeseh Hashemi, Jason B. King, James W. Tunnell, Carlo Morasso, Francesca Piccotti, Fabio Corsi, Malou Henriksen-Lacey, Dorleta Jimenez de Aberasturi, David Mendez-Merino, Alfonso Rodriguez-Paton, Sara Abalde-Cela, Lorena Dieguez
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2023)
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?
Ahmed Soliman, Lidia Bakota, Roland Brandt
CURRENT NEUROPHARMACOLOGY (2022)
Will rheumatologists ever pick up the arthroscope again?
Robert W. Ike, Kenneth C. Kalunian
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)
'Will the Spanish regions converge in a near future?'
Rafael Flores de Frutos, Manuel Leon Navarro, Sofia Tirado Sarti
APPLIED ECONOMICS (2021)
The Future of Bacteriophage Therapy Will Promote Antimicrobial Susceptibility
Olivia Williams Barber, Iria Manas Miramontes, Manu Jain, A. Egon Ozer, M. Erica Hartmann
MSYSTEMS (2021)
'That's as hard a decision as you will ever have to make': the experiences of people who discussed Do Not Attempt Cardiopulmonary Resuscitation on behalf of a relative during the COVID-19 pandemic
Louise Tomkow, Felicity Dewhurst, Michaela Hubmann, Christina Straub, Efioanwan Damisa, Barbara Hanratty, Chris Todd
AGE AND AGEING (2023)
Geopolymer Foams-Will They Ever Become a Viable Alternative to Popular Insulation Materials?-A Critical Opinion
Michal Lach
MATERIALS (2021)
Pollinator conservation: Where will bees go in the Anthropocene future?
Michael Hrncir
CURRENT BIOLOGY (2022)
What will the future make of our discoveries?
John C. Montgomery
ICES JOURNAL OF MARINE SCIENCE (2022)
Does memory research have a realistic future?
Eleanor A. Maguire
TRENDS IN COGNITIVE SCIENCES (2022)
Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure
Sandra Perez-Torras, Aida Mata-Ventosa, Britt Drogemoller, Maja Tarailo-Graovac, Judith Meijer, Rutger Meinsma, Arno G. van Cruchten, Wim Kulik, Albert Viel-Oliva, Axel Bidon-Chanal, Colin J. Ross, Wyeth W. Wassermann, Clara D. M. van Karnebeek, Marcal Pastor-Anglada, Andre B. P. van Kuilenburg
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
Linda M. Henricks, Carin A. T. C. Lunenburg, Femke M. de Man, Didier Meulendijks, Geert W. J. Frederix, Emma Kienhuis, Geert-Jan Creemers, Arnold Baars, Vincent O. Dezentje, Alexander L. T. Imholz, Frank J. F. Jeurissen, Johanna E. A. Portielje, Rob L. H. Jansen, Paul Hamberg, Albert J. ten Tije, Helga J. Droogendijk, Miriam Koopman, Peter Nieboer, Marlene H. W. van de Poel, Caroline M. P. W. Mandigers, Hilde Rosing, Jos H. Beijnen, Erik van Werkhoven, Andre B. P. van Kuilenburg, Ron H. N. van Schaik, Ron H. J. Mathijssen, Jesse J. Swen, Hans Gelderblom, Annemieke Cats, Henk-Jan Guchelaar, Jan H. M. Schellens
EUROPEAN JOURNAL OF CANCER (2019)
Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients
I. R. N. Verly, R. Leen, J. R. Meinsma, G. K. J. Hooijer, C. D. Savci-Heijink, J. van Nes, M. Broekmans, R. J. A. Wanders, A. B. P. van Kuilenburg, G. A. M. Tytgat
EUROPEAN JOURNAL OF CANCER (2019)
Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation
Mohammed H. Aldosari, Robert P. de Vries, Lucia R. Rodriguez, Nienke A. Hesen, Nataliia Beztsinna, Andre B. P. van Kuilenburg, Carla E. M. Hollak, Huub Schellekens, Enrico Mastrobattista
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Developments in the treatment of Fabry disease
Sanne J. van der Veen, Carla E. M. Hollak, Andre B. P. van Kuilenburg, Mirjam Langeveld
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers
Eline C. B. Eskes, Barbara Sjouke, Frederic M. Vaz, Susan M. I. Goorden, Andre B. P. van Kuilenburg, Johannes M. F. G. Aerts, Carla E. M. Hollak
MOLECULAR GENETICS AND METABOLISM (2020)
The Effects of Mercaptopurine on Pulmonary Vascular Resistance and BMPR2 Expression in Pulmonary Arterial Hypertension
Liza Botros, Robert Szulcek, Samara M. A. Jansen, Kondababu Kurakula, Marie-Jose T. H. Goumans, Andre B. P. van Kuilenburg, Anton Vonk Noordegraaf, Frances S. de Man, Jurjan Aman, Harm Jan Bogaard
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease
Sanne J. van der Veen, Wytze J. Vlietstra, Laura van Dussen, Andre B. P. van Kuilenburg, Marcel G. W. Dijkgraaf, Malte Lenders, Eva Brand, Christoph Wanner, Derralynn Hughes, Perry M. Elliott, Carla E. M. Hollak, Mirjam Langeveld
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients
Shanice Beerepoot, Silvy J. M. van Dooren, Gajja S. Salomons, Jaap Jan Boelens, Edwin H. Jacobs, Marjo S. van der Knaap, Andre B. P. van Kuilenburg, Nicole Wolf
NEUROGENETICS (2020)
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
Thomas Blom, Rutger Meinsma, Marja Rutgers, Corine Buitenhuis, Marieke van den Burg, Andre B. P. van Kuilenburg, Godelieve A. M. Tytgat
EJNMMI RESEARCH (2020)
Atypical presentation of Arts syndrome due to a novel hemizygous loss-of-function variant in the PRPS1 gene
Sanna Puusepp, Karit Reinson, Sander Pajusalu, Andre B. P. van Kuilenburg, Doreen Dobritzsch, Jeroen Roelofsen, Werner Stenzel, Katrin Ounap
MOLECULAR GENETICS AND METABOLISM REPORTS (2020)
Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population
Jatta Saarenheimo, Nesna Wahid, Natalja Eigeliene, Ravichandra Ravi, Gajja S. Salomons, Matilde Fernandez Ojeda, Raymon Vijzelaar, Antti Jekunen, Andre B. P. van Kuilenburg
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency)
Nina Lenherr, John Christodoulou, John Duley, Doreen Dobritzsch, Lynette Fairbanks, Alexandre N. Datta, Isabel Filges, Nicolas Guertler, Jeroen Roelofsen, Andre B. P. van Kuilenburg, Claudia Kemper, Erin E. West, Gabor Szinnai, Martina Huemer
MOLECULAR GENETICS AND METABOLISM REPORTS (2021)
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation
Andre B. P. van Kuilenburg, Carla E. M. Hollak, Ana Travella, Melisa Jacobs, Lucas D. Gentilini, Rene Leen, Karen M. M. Ghauharali van der Vlugt, Femke S. Beers Stet, Susan M. I. Goorden, Sanne van der Veen, Marcelo Criscuolo, Mariana Papouchado
DRUGS IN R&D (2023)
Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine Levels
Sanne J. van der Veen, Mohamed el Sayed, Carla E. M. Hollak, Marion M. Brands, C. Khya S. Snelder, S. Matthijs Boekholdt, Liffert Vogt, Susan M. I. Goorden, Andre B. P. van Kuilenburg, Mirjam Langeveld
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)